Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
In The Headlines: Late poet Andrea Werblin Reid’s husband talks about publishing her final collection about dying from ovarian cancer
Podcast

In The Headlines: Late poet Andrea Werblin Reid’s husband talks about publishing her final collection about dying from ovarian cancer

August 13, 2025
Vol.51 No.31
The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
FreePodcastThe Directors

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

August 08, 2025
Vol.51 No.31
By Paul Goldberg
In The Headlines: A good week for NIH, a bad week for Vinay Prasad
Podcast

In The Headlines: A good week for NIH, a bad week for Vinay Prasad

August 06, 2025
Vol.51 No.30
In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
Podcast

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

July 30, 2025
Vol.51 No.29
In the Headlines: Is oncology ready to move away from animal testing?
Podcast

In the Headlines: Is oncology ready to move away from animal testing?

July 23, 2025
Vol.51 No.28
The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
PodcastThe Directors

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

July 18, 2025
Vol.51 No.28
By Paul Goldberg and Katie Goldberg
In The Headlines: What happens when you apply a tumor board model to financial toxicity?
Podcast

In The Headlines: What happens when you apply a tumor board model to financial toxicity?

July 16, 2025
Vol.51 No.27
In The Headlines: George Weiner on the importance of patients’ stories
Podcast

In The Headlines: George Weiner on the importance of patients’ stories

July 09, 2025
Vol.51 No.26
In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
Podcast

In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”

July 02, 2025
Vol.51 No.25
In the Headlines: What if curing diseases was treated like a business?
Podcast

In the Headlines: What if curing diseases was treated like a business?

June 25, 2025
Vol.51 No.24

Posts navigation

Previous1…345678Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account